These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 33560669)

  • 21. Evinacumab for Homozygous Familial Hypercholesterolemia.
    Luo F; Das A; Fang Z
    N Engl J Med; 2021 Feb; 384(6):e17. PubMed ID: 33567206
    [No Abstract]   [Full Text] [Related]  

  • 22. Genetically determined hypercholesterolaemia results into premature leucocyte telomere length shortening and reduced haematopoietic precursors.
    Baragetti A; Bonacina F; Da Dalt L; Moregola A; Zampoleri V; Pellegatta F; Grigore L; Pirillo A; Spina R; Cefalù AB; Averna M; Norata GD; Catapano AL
    Eur J Prev Cardiol; 2022 May; 29(5):721-729. PubMed ID: 33624064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term follow-up of children with familial hypercholesterolemia and relatively normal LDL-cholesterol at diagnosis.
    Johansen AK; Bogsrud MP; Roeters van Lennep J; Narverud I; Langslet G; Retterstøl K; Holven KB
    J Clin Lipidol; 2021; 15(2):375-378. PubMed ID: 33608220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intronic variant screening with targeted next-generation sequencing reveals first pseudoexon in LDLR in familial hypercholesterolemia.
    Reeskamp LF; Balvers M; Peter J; van de Kerkhof L; Klaaijsen LN; Motazacker MM; Grefhorst A; van Riel NAW; Hovingh GK; Defesche JC; Zuurbier L
    Atherosclerosis; 2021 Mar; 321():14-20. PubMed ID: 33601267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Pharmacovigilance Study of Adverse Drug Reactions Reported for Cardiovascular Disease Medications Approved Between 2012 and 2017 in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
    Patel NM; Stottlemyer BA; Gray MP; Boyce RD; Kane-Gill SL
    Cardiovasc Drugs Ther; 2022 Apr; 36(2):309-322. PubMed ID: 33599896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia.
    Gazzotti M; Casula M; Olmastroni E; Averna M; Arca M; Catapano AL
    Atheroscler Suppl; 2020 Dec; 42():e35-e40. PubMed ID: 33589222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Closing the gap: Identification and management of familial hypercholesterolemia in an integrated healthcare delivery system.
    Birnbaum RA; Horton BH; Gidding SS; Brenman LM; Macapinlac BA; Avins AL
    J Clin Lipidol; 2021; 15(2):347-357. PubMed ID: 33583725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics education program to help public health nurses improve their knowledge and enhance communities' genetic literacy: a pilot study.
    Kawasaki H; Kawasaki M; Iki T; Matsuyama R
    BMC Nurs; 2021 Feb; 20(1):31. PubMed ID: 33579269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evinacumab for Homozygous Familial Hypercholesterolemia. Reply.
    Raal FJ; Gaudet D; Gusarova V
    N Engl J Med; 2021 Feb; 384(6):e17. PubMed ID: 33567208
    [No Abstract]   [Full Text] [Related]  

  • 30. Evinacumab for Homozygous Familial Hypercholesterolemia.
    Xu HG
    N Engl J Med; 2021 Feb; 384(6):e17. PubMed ID: 33567207
    [No Abstract]   [Full Text] [Related]  

  • 31. New and Emerging Therapies for Reduction of LDL-Cholesterol and Apolipoprotein B: JACC Focus Seminar 1/4.
    Nurmohamed NS; Navar AM; Kastelein JJP
    J Am Coll Cardiol; 2021 Mar; 77(12):1564-1575. PubMed ID: 33766264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic Risk Assessment for Atherosclerotic Cardiovascular Disease: A Guide for the General Cardiologist.
    Belanger MJ; Kelly EM; Tahir UA; Benson MD
    Cardiol Rev; 2022 Jul-Aug 01; 30(4):206-213. PubMed ID: 33758125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genome-wide association analysis in dilated cardiomyopathy reveals two new players in systolic heart failure on chromosomes 3p25.1 and 22q11.23.
    Garnier S; Harakalova M; Weiss S; Mokry M; Regitz-Zagrosek V; Hengstenberg C; Cappola TP; Isnard R; Arbustini E; Cook SA; van Setten J; Calis JJA; Hakonarson H; Morley MP; Stark K; Prasad SK; Li J; O'Regan DP; Grasso M; Müller-Nurasyid M; Meitinger T; Empana JP; Strauch K; Waldenberger M; Marguiles KB; Seidman CE; Kararigas G; Meder B; Haas J; Boutouyrie P; Lacolley P; Jouven X; Erdmann J; Blankenberg S; Wichter T; Ruppert V; Tavazzi L; Dubourg O; Roizes G; Dorent R; de Groote P; Fauchier L; Trochu JN; Aupetit JF; Bilinska ZT; Germain M; Völker U; Hemerich D; Raji I; Bacq-Daian D; Proust C; Remior P; Gomez-Bueno M; Lehnert K; Maas R; Olaso R; Saripella GV; Felix SB; McGinn S; Duboscq-Bidot L; van Mil A; Besse C; Fontaine V; Blanché H; Ader F; Keating B; Curjol A; Boland A; Komajda M; Cambien F; Deleuze JF; Dörr M; Asselbergs FW; Villard E; Trégouët DA; Charron P
    Eur Heart J; 2021 May; 42(20):2000-2011. PubMed ID: 33677556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Machine learning modelling of blood lipid biomarkers in familial hypercholesterolaemia versus polygenic/environmental dyslipidaemia.
    Correia M; Kagenaar E; van Schalkwijk DB; Bourbon M; Gama-Carvalho M
    Sci Rep; 2021 Feb; 11(1):3801. PubMed ID: 33589716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of the causal relevance of ECG parameters for risk of atrial fibrillation: A mendelian randomisation study.
    Gajendragadkar PR; Von Ende A; Ibrahim M; Valdes-Marquez E; Camm CF; Murgia F; Stiby A; Casadei B; Hopewell JC
    PLoS Med; 2021 May; 18(5):e1003572. PubMed ID: 33983917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improving reporting standards for polygenic scores in risk prediction studies.
    Wand H; Lambert SA; Tamburro C; Iacocca MA; O'Sullivan JW; Sillari C; Kullo IJ; Rowley R; Dron JS; Brockman D; Venner E; McCarthy MI; Antoniou AC; Easton DF; Hegele RA; Khera AV; Chatterjee N; Kooperberg C; Edwards K; Vlessis K; Kinnear K; Danesh JN; Parkinson H; Ramos EM; Roberts MC; Ormond KE; Khoury MJ; Janssens ACJW; Goddard KAB; Kraft P; MacArthur JAL; Inouye M; Wojcik GL
    Nature; 2021 Mar; 591(7849):211-219. PubMed ID: 33692554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calculating Polygenic Risk Scores (PRS) in UK Biobank: A Practical Guide for Epidemiologists.
    Collister JA; Liu X; Clifton L
    Front Genet; 2022; 13():818574. PubMed ID: 35251129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic prediction of complex traits with polygenic scores: a statistical review.
    Ma Y; Zhou X
    Trends Genet; 2021 Nov; 37(11):995-1011. PubMed ID: 34243982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resource profile and user guide of the Polygenic Index Repository.
    Becker J; Burik CAP; Goldman G; Wang N; Jayashankar H; Bennett M; Belsky DW; Karlsson Linnér R; Ahlskog R; Kleinman A; Hinds DA; ; Caspi A; Corcoran DL; Moffitt TE; Poulton R; Sugden K; Williams BS; Harris KM; Steptoe A; Ajnakina O; Milani L; Esko T; Iacono WG; McGue M; Magnusson PKE; Mallard TT; Harden KP; Tucker-Drob EM; Herd P; Freese J; Young A; Beauchamp JP; Koellinger PD; Oskarsson S; Johannesson M; Visscher PM; Meyer MN; Laibson D; Cesarini D; Benjamin DJ; Turley P; Okbay A
    Nat Hum Behav; 2021 Dec; 5(12):1744-1758. PubMed ID: 34140656
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polygenic risk scores for low-density lipoprotein cholesterol and familial hypercholesterolemia.
    Nomura A; Sato T; Tada H; Kannon T; Hosomichi K; Tsujiguchi H; Nakamura H; Takamura M; Tajima A; Kawashiri MA
    J Hum Genet; 2021 Nov; 66(11):1079-1087. PubMed ID: 33967275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.